| MSKCC HDAM | MDACC CVAD | NYMC HDAM | NYMC CVAD | |
|---|---|---|---|---|
| Patient No. | 37 | 204 | 52 | 21 |
| Median age (range) | 39 (18-72) | 39.5 (16-79) | 35 (19-78) | 29 (19-68) |
| Men | 60% | 65% | 62% | 52% |
| Ph+ | 17% | 16% | 9% | 5% |
| WBC | 28 | 7.7 | 8 | 14 |
| B | 71% | 76% | 86% | 52% |
| T | 28% | 18% | 14% | 34% |
| AlloSCT | 9% | NA | 8% | 14% |
| CR | 83% | 91% | 87% | 76% |
| Induction Death | 9% | 6% | 9% | 5% |
| Resistant disease | 8% | 3% | 4% | 19% |
| Time to CR(median) | 32 | 21 | 29 | 27 |
| 5yr OS | 35% | 39% | 30% | NA |
| Median OS(months) | 24 | 35 | 21 | 27 |
| CR in Ph+ (No) | 85% | 91% | 100%(6) | 100%(1) |
| 5yr OS in Ph+ | 26% | 7% | NA | NA |